The ASK Real-World Evidence UK case study has now launched, the third regional case study within the programme, focusing on the adoption of oncology biosimilars in the UK healthcare system.

The ASK Real-World Evidence UK case study will cover the implementation of biosimilars medications within the UK National Health Service (NHS), with a focus on the Cancer Vanguard Project in NHS England. Developed with Emma Foreman, Consultant Pharmacist at the Royal Marsden Hospital, this case study outlines the oncology biosimilars landscape in the UK and discusses the benefits of oncology medications to the UK healthcare system.

Alongside the case studies, you can also explore the education hub which offers additional free education including the real-world evidence abstract library, a core handbook, on-demand webinars, resource library, and learning chapters. Helping to expand your knowledge on the use of biosimilars in the treatment of cancer.

The programme’s resources are specifically targeting oncologists, oncology nurses, and hospital pharmacists in Europe, United States, Canada, Australia and globally. Marketing of the resources is done via the ASK Real-World Evidence community, as well as our media brands Hospital Healthcare Europe and Hospital Pharmacy Europe.